Interleukin-6 plays a key role in the chronic inflammation associated with rheumatoid arthritis (RA), and blocking IL-6 signaling is an important strategy in treating RA-associated diseases clinically [46]. This evidence concerns the gene IL6 and rheumatoid arthritis.